MEDS TRxADE: Rasio Kapitalisasi Pasar marang Nilai Buku

Simbol resmi perusahaan TRxADE (MEDS)

The current price-to-book ratio helps evaluate the TRxADE HEALTH (MEDS) B2B marketplace for pharmacy drug procurement. Management is developing a digital ecosystem and telemedicine, while a radical overhaul of the logistics structure is temporarily impacting profits. The value of -0.30 serves as the parameter's baseline, making it possible to identify the divergence between investor expectations and the actual value of the company's assets.

MEDS Multiplikator Kapitalisasi Pasar marang Nilai Buku trxadehealth.com (04.07.2022 - 28.10.2026)
Produk dadi TRxADE HEALTH Inc

The market-to-book ratio measures a business's ability to maintain a premium over net assets during periods of market volatility. This metric is calculated as the quotient of the market valuation and shareholders' equity, reflecting investor sensitivity to asset quality. The price action of the market-to-book ratio reveals the value's margin of safety. For TRxADE HEALTH, Inc. (MEDS), this is critical during its transformation into an IT ecosystem and the implementation of AI amid the outflow of traditional B2B clients.

Pesaing utama

Veeva Systems Inc. - Rasio Nilai Pasar marang Nilai Buku|doximity.com (DOCS) - Kapitalisasi Pasar marang Nilai Buku|HQY: Rasio Kapitalisasi Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku Waystar Health (WAY)|Rasio Kapitalisasi marang Aset Bersih CorVel Healthcare|Multiplikator Kapitalisasi Pasar marang Nilai Buku Privia Medical Group PRVA|Rasio Kapitalisasi marang Aset Bersih Huron Consulting Group|certara.com - Nilai Pasar marang Nilai Buku|OMCL: Rasio Nilai Pasar marang Nilai Buku|GDRX - Rasio Kapitalisasi marang Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku SDGR|Phreesia Health (PHR) - Koefisien Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku Omada Health Inc (OMDA)|Rasio Kapitalisasi marang Nilai Buku evolenthealth.com (EVH)|Rasio Kapitalisasi marang Aset Bersih HealthStream|Multiplikator Kapitalisasi Pasar marang Nilai Buku DH (Definitive Healthcare Corp)|Rasio Nilai Pasar marang Nilai Buku Consensus|AGL - Nilai Pasar marang Nilai Buku|Absci (ABSI) - Rasio Kapitalisasi marang Aset Bersih|SY - Rasio Kapitalisasi marang Nilai Buku|NRC: Rasio Kapitalisasi Pasar marang Nilai Buku|Spok Holdings Inc (SPOK) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku OptimizeRx Corp. (OPRX)|Rasio Kapitalisasi marang Nilai Buku TruBridge Corp|Simulations Plus, Inc. - Rasio Kapitalisasi Pasar marang Nilai Buku|Koefisien Nilai Pasar marang Nilai Buku sophiagenetics.com SOPH|Rasio Kapitalisasi marang Aset Bersih Health Catalyst|Nilai Pasar marang Nilai Buku CareCloud Inc. CCLD|Rasio Kapitalisasi Pasar marang Nilai Buku Research Solutions, Inc. (RSSS)|DLHC - Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku ONMD|scienture.com (SCNX) - Koefisien Nilai Pasar marang Nilai Buku|HCTI (Healthcare Triangle, Inc.) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku ISPC|Rasio Nilai Pasar marang Nilai Buku Bullfrog AI Holdings (BFRG)|Rasio Nilai Pasar marang Nilai Buku SCWorx Inc WORX|Rasio Kapitalisasi marang Aset Bersih MSP Recovery Inc (MSPR)|Multiplikator Kapitalisasi Pasar marang Nilai Buku iCoreConnect, Inc. ICCT|Rasio Kapitalisasi Pasar marang Nilai Buku Orgenesis (ORGS)|R1 RCM Inc. (RCM) - Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih Sharecare, Inc SHCR|Streamline Health, Inc. (STRM) - Nilai Pasar marang Nilai Buku|SYRA: Rasio Kapitalisasi Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku AMEH|Rasio Nilai Pasar marang Nilai Buku Model N MODN|Rasio Kapitalisasi marang Nilai Buku NextGen Healthcare Inc (NXGN)